methylphenidate hydrochloride - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
CONCERTA methylphenidate hydrochloride 18mg modified release tablet bottle
AUST R: 93862
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Tablet, modified release

Sponsor:
Janssen-Cilag Pty Ltd

Phone:
1800226334

From
29 Oct 2024
to
31 Dec 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
The sponsor is closely monitoring the supply.Patients are advised to consult their healthcare professional to discuss their options. An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd can be contacted for details on supply on 1300 788 261.
CONCERTA methylphenidate hydrochloride 27mg modified release tablet bottle
AUST R: 124502
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Tablet, modified release

Sponsor:
Janssen-Cilag Pty Ltd

Phone:
1800226334

From
19 Dec 2024
to
31 Dec 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
The sponsor is closely monitoring the supply.Patients are advised to consult their healthcare professional to discuss their options. An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd can be contacted for details on supply on 1300 788 261.
CONCERTA methylphenidate hydrochloride 36mg modified release tablet bottle
AUST R: 93863
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Tablet, modified release

Sponsor:
Janssen-Cilag Pty Ltd

Phone:
1800226334

From
16 Dec 2024
to
31 Dec 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
The sponsor is closely monitoring the supply.Patients are advised to consult their healthcare professional to discuss their options. An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd can be contacted for details on supply on 1300 788 261.
CONCERTA methylphenidate hydrochloride 54mg modified release tablet bottle
AUST R: 93864
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Tablet, modified release

Sponsor:
Janssen-Cilag Pty Ltd

Phone:
1800226334

From
16 Oct 2024
to
31 Dec 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
The sponsor is closely monitoring the supply.Patients are advised to consult their healthcare professional to discuss their options. An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd can be contacted for details on supply on 1300 788 261.
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 18 mg modified release tablet bottle
AUST R: 370912
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Tablet, modified release

Sponsor:
Teva Pharma Australia Pty Ltd

Phone:
1800 288 382

From
04 Sep 2024
to
31 Dec 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in demand due to other sponsors unable to supply

Management action:
The sponsor is closely monitoring the supply.Patients are advised to consult their healthcare professional to discuss their options. An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd can be contacted for details on supply on 1300 788 261.
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 27 mg modified release tablet bottle
AUST R: 370911
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Tablet, modified release

Sponsor:
Teva Pharma Australia Pty Ltd

Phone:
1800 288 382

From
14 Jan 2025
to
31 Dec 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in demand due to other sponsors unable to supply

Management action:
The sponsor is closely monitoring the supply.Patients are advised to consult their healthcare professional to discuss their options. An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd can be contacted for details on supply on 1300 788 261.
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 36 mg modified release tablet bottle
AUST R: 370900
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Tablet, modified release

Sponsor:
Teva Pharma Australia Pty Ltd

Phone:
1800 288 382

From
14 Jan 2025
to
31 Dec 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in demand due to other sponsors unable to supply

Management action:
The sponsor is closely monitoring the supply.Patients are advised to consult their healthcare professional to discuss their options. An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd can be contacted for details on supply on 1300 788 261.
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 54 mg modified release tablet bottle
AUST R: 370899
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Tablet, modified release

Sponsor:
Teva Pharma Australia Pty Ltd

Phone:
1800 288 382

From
30 Sep 2024
to
31 Dec 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in demand due to other sponsors unable to supply

Management action:
The sponsor is closely monitoring the supply.Patients are advised to consult their healthcare professional to discuss their options. An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd can be contacted for details on supply on 1300 788 261.
RITALIN LA methylphenidate hydrochloride 40mg modified release capsule bottle
AUST R: 82959
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Capsule, modified release

Sponsor:
Novartis Pharmaceuticals Australia Pty Ltd

Phone:
0298053555

From
26 Mar 2025
to
28 Mar 2025

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
The sponsor is closely controlling the supply. A generic product is available.
METHYLPHENIDATE XR ARX methylphenidate hydrochloride 27 mg modified release tablet bottle
AUST R: 344270
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Tablet, modified release

Sponsor:
Teva Pharma Australia Pty Ltd

Phone:
1800 195 055

Deletion from market:
31 Jul 2024

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Manufacturing

Management action:
Alternative generic products are available.
METHYLPHENIDATE XR ARX methylphenidate hydrochloride 36 mg modified release tablet bottle
AUST R: 344277
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Tablet, modified release

Sponsor:
Teva Pharma Australia Pty Ltd

Phone:
1800 195 055

Deletion from market:
31 Jul 2024

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Manufacturing

Management action:
An alternative generic product is available.
METHYLPHENIDATE XR ARX methylphenidate hydrochloride 54 mg modified release tablet bottle
AUST R: 344275
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Tablet, modified release

Sponsor:
Teva Pharma Australia Pty Ltd

Phone:
1800 195 055

Deletion from market:
31 Jul 2024

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Manufacturing

Management action:
The sponsor is closely monitoring the supply.Patients are advised to consult their healthcare professional to discuss their options. An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd can be contacted for details on supply on 1300 788 261.
METHYLPHENIDATE XR ARX methylphenidate hydrochloride18 mg modified release tablet bottle
AUST R: 344274
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Tablet, modified release

Sponsor:
Teva Pharma Australia Pty Ltd

Phone:
1800 195 055

Deletion from market:
30 Jun 2024

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Manufacturing

Management action:
An alternative generic product is available.